September 14, 2021, Vol 326, No. 10, Pages 889-984
Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations
G. Owen Schaefer, DPhil; R. J. Leland, PhD; Ezekiel J. Emanuel, MD, PhD
JAMA. 2021;326(10):903-904. doi:10.1001/jama.2021.13226
This Viewpoint highlights countries with higher concentrations of COVID-19–vaccinated residents and and excess vaccine supply vs those without, and it emphasizes the clinical and ethical reasons for prioritizing distribution of excess vaccine to underserved countries instead of keeping it for booster administration.